Disrupting mGluR3 targets glioma stem-like cells and diminishes glutamatergic metabotropic crosstalk with the ionotropic receptor, illustrating the relationship between glutamate and excitatory enhancement in glioma cells [32]. This evidence concerns the gene GRM3 and central nervous system cancer.